Li Juan

23PUBLICATIONS
34CO-AUTHORS
Medical mycologyMolecular targetsPredictive and prognostic markersMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 26, 2026
The Prognostic Significance of Dynamic Monitoring of Minimal Residual Disease Status in Patients with Multiple Myeloma: A Real-World Study.

|Sep 26, 2026
The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma.

|Jul 26, 2026
Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real-world analysis from the Chinese Myeloma Committee.

|Jun 12, 2026
Clinical implications and predictors of MRD resurgence in ASCT-eligible patients with NDMM: a real-world study in China.

|May 27, 2026
Sustained MRD Negative for 4 Years Is a Significant Marker of Prognosis in Patients with High-Risk Multiple Myeloma.

|May 10, 2026
Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation.

Pageof 4

Frequent Collaborators

5 joint publications

Junru Liu

3 joint publications

Juan Du

2 joint publications

Yuan Jian

2 joint publications

Zhiyao Zhang